Fanconi Anemia Drug Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global fanconi anemia drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Fanconi anemia is a rare inherited disease. It mainly affects the bone marrow and results in decreased production of all types of blood cells. Additionally, it is the most common inherited form of aplastic anemia and is different from fanconi syndrome. The major factor driving the demand for Fanconi anemia drugs is the increasing prevalence of the fanconi anemia across the globe.
According to the National Center
for Biotechnology Information (NCBI), Fanconi anemia is a very rare type of
anemia with a prevalence rate of an average of 1 out of 136,000 newborns.
Additionally, it varies from 1 in 100,000 to 250,000 births. Furthermore, half
the patients are diagnosed before age 10 while about 10% are diagnosed as
adults. Moreover, the condition is more common among people of Ashkenazi Jewish
descent, the Roma population of Spain, and black South Africans. Hence, the
increasing prevalence of fanconi anemia is driving the demand for fanconi
anemia drugs for treatment which in turn is driving the growth of the market.
To Request a Sample of our Report on Fanconi Anemia Drug
Market: https://www.omrglobal.com/request-sample/fanconi-anemia-drug-market
Some major players in the market include Abeona Therapeutics
Inc., Genethon SA, and Novartis International AG, among others. The market
players are contributing significantly to the growth of the market by the
adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in December 2021,
Rocket Pharmaceuticals, Inc. announced the positive clinical updates from its
ongoing Phase 2 registrational trials for Fanconi Anemia (FA) and Leukocyte
Adhesion Deficiency-I (LAD-I) and its ongoing Phase 1 trial for Pyruvate Kinase
Deficiency (PKD) at the 63rd American Society of Hematology (ASH) Annual
Meeting.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Abeona Therapeutics Inc.,
Genethon SA, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Fanconi Anemia Drug Market is Available @ https://www.omrglobal.com/industry-reports/fanconi-anemia-drug-market
Global Fanconi Anemia Drug Market Report by Segment
By Type
• Eltrombopag
Olamine
• EXG-34217
• Fancalen
• Others
By Application
• Hospital
• Clinic
• Others
Global Fanconi Anemia Drug Market Report Segment by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment